With regard to the kidney, this is even less understood, but the issue may be clarified once major kidney studies of agonists such as the dual GIP/GLP-1 agonist tirzepatide are completed (discussed below)
Morning Mineral Anchor: Start your day with a dedicated electrolyte drink
In saliva, studies by Ciregia et al
For patients with significant weight loss goals, FDA-approved options backed by stronger clinical evidence may be more appropriate as a primary treatment
What exists is based on animal research, off-label veterinary protocols, and clinical experience
Why Ipamorelin avoids cortisol and prolactin spillover Ipamorelin is a selective GHS-R1a agonist that produced GH release comparable to GHRP-6 in rats without measurable elevation of ACTH, cortisol or prolactin at GH-releasing doses (Raun et al., 1998)